Home » Stocks » IRIX

IRIDEX Corporation (IRIX)

Stock Price: $6.57 USD 0.10 (1.55%)
Updated Aug 3, 2021 11:38 AM EDT - Market open
Market Cap 101.98M
Revenue (ttm) 39.29M
Net Income (ttm) -6.69M
Shares Out 15.76M
EPS (ttm) -0.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day August 3
Last Price $6.57
Previous Close $6.47
Change ($) 0.10
Change (%) 1.55%
Day's Open 6.50
Day's Range 6.47 - 6.61
Day's Volume 11,600
52-Week Range 1.60 - 9.71

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

MOUNTAIN VIEW, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021.

2 months ago - GlobeNewsWire

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Iridex's (IRIX) fourth-quarter 2020 results benefit from strong product line-up and expanding market position.

4 months ago - Zacks Investment Research

Iridex (IRIX) delivered earnings and revenue surprises of 90.91% and 0.40%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Shares of Iridex (NASDAQ:IRIX) decreased 0.4% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 90.91% year over year to ($0.01), which beat t...

4 months ago - Benzinga

MOUNTAIN VIEW, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended January 2, 2021.

4 months ago - GlobeNewsWire

Iridex (NASDAQ:IRIX) releases its next round of earnings this Monday, March 22. Here is Benzinga's essential guide to Iridex's Q4 earnings report.

4 months ago - Benzinga

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal di...

4 months ago - GlobeNewsWire

MOUNTAIN VIEW, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal di...

4 months ago - GlobeNewsWire

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal di...

5 months ago - GlobeNewsWire

MOUNTAIN VIEW, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year end...

6 months ago - GlobeNewsWire

Iridex Corp. seems to be at the initial stage of a growth inflection that could drive the stock up 175-625%. IRIX has a commercial product which could revolutionize glaucoma treatment, with an addressab...

6 months ago - Seeking Alpha

MOUNTAIN VIEW, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal dis...

7 months ago - GlobeNewsWire

IRIDEX's (IRIX) CEO Dave Bruce on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Iridex (IRIX) delivered earnings and revenue surprises of 33.33% and 13.08%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 26, 2020.

8 months ago - GlobeNewsWire

Iridex (NASDAQ: IRIX) unveils its next round of earnings this Monday, November 09. Get prepared with Benzinga's ultimate preview for Iridex's Q3 earnings.

8 months ago - Benzinga

MOUNTAIN VIEW, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Virtual Healthcare Conference.

8 months ago - GlobeNewsWire

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2020 after the close of tra...

9 months ago - GlobeNewsWire

IRIDEX's (IRIX) CEO Dave Bruce on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Iridex Corporation: Deserves More Patience Given Shift In Commercial Strategy And Aggressive Cost Cutting

11 months ago - Seeking Alpha

MOUNTAIN VIEW, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 27, 2020.

11 months ago - GlobeNewsWire

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

MOUNTAIN VIEW, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2020 after the close of ...

1 year ago - GlobeNewsWire

IRIDEX Corporation (IRIX) CEO David Bruce on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Names Prior CFO/COO as Interim CFO Names Prior CFO/COO as Interim CFO

1 year ago - GlobeNewsWire

IRIDEX Corp (IRIX) CEO David Bruce on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Iridex (IRIX) delivered earnings and revenue surprises of 31.25% and 0.53%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

IRIDEX Corp (IRIX) CEO David Bruce on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

MOUNTAIN VIEW, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019. Concurr...

1 year ago - GlobeNewsWire

MOUNTAIN VIEW, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal ...

1 year ago - GlobeNewsWire

Laser Systems & Components Industry Outlook: Prospects Bright

Other stocks mentioned: CUTR, LITE
1 year ago - Zacks Investment Research

Iridex (IRIX) delivered earnings and revenue surprises of 18.18% and -4.70%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

IRIDEX Corp (IRIX) CEO William Moore on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Iridex (IRIX) delivered earnings and revenue surprises of 8.33% and 1.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems tha... [Read more...]

Industry
Medical Devices
IPO Date
Feb 15, 1996
Stock Exchange
NASDAQ
Ticker Symbol
IRIX
Full Company Profile

Financial Performance

In 2020, IRIX's revenue was $36.35 million, a decrease of -16.34% compared to the previous year's $43.45 million. Losses were -$6.33 million, -28.19% less than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for IRIX stock is "Buy." The 12-month stock price forecast is 10.50, which is an increase of 59.82% from the latest price.

Price Target
$10.50
(59.82% upside)
Analyst Consensus: Buy